Meglumine gadopentetate

Generic Medicine Info
Special Precautions
Patients with severe renal impairment, epilepsy, hypotension, sickle cell anaemia, children <2 yr, a history of hypersensitivity, asthma or other allergic respiratory disorders. Care should be taken to avoid extravasation. Caution when used in patients with conditions predisposed to development of thrombotic syndromes. Caution when interpreting a contrast enhanced scan in the absence of a companion unenhanced MRI.
Adverse Reactions
Headache, nausea, vomiting, paraesthesias, dizziness and localised pain. Transient sensations of heat or cold or taste disturbances on inj of gadopentetate or other gadolinium chelates. Rarely, convulsions, hypotension, allergic or anaphylactoid reactions and shock may occur.
Potentially Fatal: Severe anaphylactic reactions.
CIMS Class
ATC Classification
V08CA01 - gadopentetic acid ; Belongs to the class of paramagnetic agents used as magnetic resonance imaging contrast media.
Disclaimer: This information is independently developed by CIMS based on meglumine gadopentetate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in